{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T08:22:47Z","timestamp":1649146967737},"reference-count":0,"publisher":"American Physiological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Heart and Circulatory Physiology"],"published-print":{"date-parts":[[1997,3,1]]},"abstract":"<jats:p> Responses to T-kinin, a peptide formed from the acute-phase substrate T-kininogen, were investigated in the hindlimb vascular bed of the cat. Under constant-flow conditions, injections of T-kinin into the perfusion circuit in doses of 0.03-1 nmol induced rapid dose-related decreases in perfusion pressure. Responses to T-kinin were similar in time course and magnitude to responses to bradykinin and kallidin and were inhibited by the kinin B2-receptor antagonist, Hoe-140. Responses to T-kinin were attenuated by an inhibitor of nitric oxide synthase and by tetraethylammonium chloride and were enhanced in duration by the guanosine 3',5'-cyclic monophosphate (cGMP) phosphodiesterase inhibitor zaprinast. Responses to T-kinin were not altered by inhibitors of K+(ATP) channels, by the cyclooxygenase pathway, or by muscarinic or beta-adrenergic-receptor antagonists. These data suggest that vasodilator responses to T-kinin are mediated by kinin B2-receptor-stimulated release of nitric oxide from the endothelium and increased smooth muscle cGMP levels. These results indicate that activation of K+(ATP) channels and muscarinic or beta-adrenergic receptors and the release of vasodilator prostaglandins are not involved in mediating the response to T-kinin in the hindlimb circulation of the cat. <\/jats:p>","DOI":"10.1152\/ajpheart.1997.272.3.h1491","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T05:57:40Z","timestamp":1513922260000},"page":"H1491-H1498","source":"Crossref","is-referenced-by-count":0,"title":["T-kinin has endothelium-dependent vasodilator activity in the cat"],"prefix":"10.1152","volume":"272","author":[{"given":"J. A.","family":"Santiago","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Tulane University School of Medicine, NewOrleans, Louisiana 70112, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. C.","family":"Champion","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Tulane University School of Medicine, NewOrleans, Louisiana 70112, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"Kadowitz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Tulane University School of Medicine, NewOrleans, Louisiana 70112, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","container-title":["American Journal of Physiology-Heart and Circulatory Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpheart.1997.272.3.H1491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T17:12:12Z","timestamp":1567962732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpheart.1997.272.3.H1491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,3,1]]}},"alternative-id":["10.1152\/ajpheart.1997.272.3.H1491"],"URL":"https:\/\/doi.org\/10.1152\/ajpheart.1997.272.3.h1491","relation":{},"ISSN":["0363-6135","1522-1539"],"issn-type":[{"value":"0363-6135","type":"print"},{"value":"1522-1539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,3,1]]}}}